Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Kidney Transplant Recipients”

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT00693446
What this trial is testing

Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

Who this might be right for
Pancreas TransplantationKidney Transplantation
Nantes University Hospital 118
Large-scale testing (Phase 3)Study completedNCT00239785
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Large-scale testing (Phase 3)Study completedNCT00098241
What this trial is testing

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 45
Large-scale testing (Phase 3)Ended earlyNCT01442337
What this trial is testing

Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 21
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40
Post-approval studies (Phase 4)UnknownNCT03828682
What this trial is testing

Veloxis de Novo Kidney Transplant ECSWD

Who this might be right for
Kidney TransplantationImmunosuppression
Simon Tremblay, PharmD, PhD 60
Large-scale testing (Phase 3)Study completedNCT00378014
What this trial is testing

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 276
Post-approval studies (Phase 4)Study completedNCT01183247
What this trial is testing

An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

Who this might be right for
Comparative StudyImmunosuppressive Agents
University Hospital, Basel, Switzerland 63
Testing effectiveness (Phase 2)Study completedNCT00239798
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 255
Large-scale testing (Phase 3)Study completedNCT06001320
What this trial is testing

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

Who this might be right for
Kidney Transplant; ComplicationsCMV
Virginia Commonwealth University 30
Large-scale testing (Phase 3)Study completedNCT00064701
What this trial is testing

Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 668
Testing effectiveness (Phase 2)Study completedNCT01064791
What this trial is testing

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 298
Post-approval studies (Phase 4)Study completedNCT00195429
What this trial is testing

A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney FailureGraft vs Host Disease
Wyeth is now a wholly owned subsidiary of Pfizer 47
Large-scale testing (Phase 3)Study completedNCT01114529
What this trial is testing

Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 828
Large-scale testing (Phase 3)Study completedNCT01025817
What this trial is testing

Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 613
Testing effectiveness (Phase 2)Study completedNCT00257387
What this trial is testing

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 120
Not applicableWithdrawnNCT01612299
What this trial is testing

Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

Who this might be right for
Renal Transplant
University of Kentucky
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Post-approval studies (Phase 4)Study completedNCT00261820
What this trial is testing

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 160
Post-approval studies (Phase 4)Study completedNCT01742624
What this trial is testing

Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

Who this might be right for
de Novo Kidney Transplantation
Astellas Pharma Korea, Inc. 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation